These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35977122)

  • 1. Large Increases in the Risk of Cardiovascular Events Following COVID-19 Infection That Required Hospitalization.
    Ebell MH
    Am Fam Physician; 2022 Aug; 106(2):Online. PubMed ID: 35977122
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 infection markedly increases long-term cardiovascular risk.
    Liuzzo G; Volpe M
    Eur Heart J; 2022 May; 43(20):1899-1900. PubMed ID: 35362024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular events after COVID-19 hospitalization: long-term follow-up.
    Negreira-Caamaño M; Martínez-Del Río J; Águila-Gordo D; Mateo-Gómez C; Soto-Pérez M; Piqueras-Flores J
    Rev Esp Cardiol (Engl Ed); 2022 Jan; 75(1):100-102. PubMed ID: 34583913
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease.
    Mensah GA; Vaduganathan M; Roth GA
    J Am Coll Cardiol; 2023 Feb; 81(6):570-573. PubMed ID: 36754517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Insight Into Pathophysiology, Epidemiology, and Management of Cardiovascular Complications of SARS-CoV-2 Infection, Post-acute COVID Syndrome, and COVID Vaccine.
    Davoudi F; Miyashita S; Yoo TK; Lee PT; Foster GP
    Crit Pathw Cardiol; 2022 Sep; 21(3):123-129. PubMed ID: 35994720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Hyperglycemia on Cardiovascular Events and Clinical Outcomes in Patients Hospitalized With COVID-19 Pneumonia.
    Krishnasamy S; Sheikh D; Ali T; Clemons V; Furmanek S; Mohamed Fawzy Abdelhaleem AA; Salunkhe V; Akbar UA; Chlebowy D; Ramirez J; Arnold F
    Endocr Pract; 2022 Aug; 28(8):780-786. PubMed ID: 35671878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients.
    Martinot M; Eyriey M; Gravier S; Bonijoly T; Kayser D; Ion C; Mohseni-Zadeh M; Camara S; Dubois J; Haerrel E; Drouaine J; Kaiser J; Ongagna JC; Schieber-Pachart A; Kempf C;
    Infect Dis Now; 2021 Sep; 51(6):518-525. PubMed ID: 34242842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heartbeat: higher risk of COVID-19 infection in younger patients with cardiovascular disease.
    Otto CM
    Heart; 2021 Mar; 107(5):345-347. PubMed ID: 33574131
    [No Abstract]   [Full Text] [Related]  

  • 9. Competing risk largely explains the drop in admissions for acute cardiovascular disease during the COVID-19 pandemic. Response.
    Ribera A; Mauri Ferré J; Romaguera R
    Rev Esp Cardiol (Engl Ed); 2020 Dec; 73(12):1085. PubMed ID: 33039379
    [No Abstract]   [Full Text] [Related]  

  • 10. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry.
    Gómez-Mesa JE; Galindo-Coral S; Montes MC; Alarco W; Barisani JL; Magaña A; Perna ER; Romero A; Speranza M; Mendoza I; Wyss F
    Glob Heart; 2021 Feb; 16(1):14. PubMed ID: 33833938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Status of SARS-CoV-2 on Cardiovascular System Injury in Children.
    Zhang Y; Wang L; Wei S
    Braz J Cardiovasc Surg; 2021 Oct; 36(5):685-690. PubMed ID: 33355798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidable Cardiovascular Events: A Serious Side Effect of the COVID-19 Pandemic.
    Cesena FHY
    Arq Bras Cardiol; 2021 Mar; 116(3):381-382. PubMed ID: 33909763
    [No Abstract]   [Full Text] [Related]  

  • 13. Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19.
    Buckley BJR; Harrison SL; Fazio-Eynullayeva E; Underhill P; Jones ID; Williams N; Lip GYH
    Eur J Prev Cardiol; 2022 Feb; 29(1):e32-e34. PubMed ID: 34219154
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis.
    Sabatino J; De Rosa S; Di Salvo G; Indolfi C
    PLoS One; 2020; 15(8):e0237131. PubMed ID: 32797054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
    Biscetti F; Rando MM; Nardella E; Cecchini AL; Bruno P; Landolfi R; Flex A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myocardial injury as a sole presentation of COVID-19 in patient without cardiovascular risk factors.
    Filipiak-Strzecka D; Plewka M; Szymczyk E; Frynas-Jończyk K; Szymczyk K; Lipiec P; Kasprzak JD
    Cardiol J; 2022; 29(5):878-879. PubMed ID: 36196658
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 and Cardiovascular Health.
    Berglund J
    IEEE Pulse; 2021; 12(5):2-5. PubMed ID: 34714732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [COVID-19 and cardiovascular diseases].
    Chazova IE; Mironova OI
    Ter Arkh; 2020 Oct; 92(9):4-7. PubMed ID: 33346424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
    Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.